VERIFY Trademark

Trademark Overview

On Monday, July 8, 2019, a trademark application was filed for VERIFY with the United States Patent and Trademark Office. The USPTO has given the VERIFY trademark a serial number of 88503872. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, May 10, 2022. This trademark is owned by Novartis AG. The VERIFY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials to medical and research professionals
verify

General Information

Serial Number88503872
Word MarkVERIFY
Filing DateMonday, July 8, 2019
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, May 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 10, 2019

Trademark Statements

Description of MarkThe mark consists of the word "VERIFY" in blue preceded by the stylized image of a flower in green.
Indication of Colors claimedThe color(s) blue and green is/are claimed as a feature of the mark.
Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials to medical and research professionals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 16, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4002
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel 4002
CH

Trademark Events

Event DateEvent Description
Wednesday, May 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 10, 2022SOU EXTENSION 5 GRANTED
Monday, May 2, 2022SOU EXTENSION 5 FILED
Saturday, May 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 2, 2022TEAS EXTENSION RECEIVED
Wednesday, November 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 1, 2021SOU EXTENSION 4 GRANTED
Monday, November 1, 2021SOU EXTENSION 4 FILED
Monday, November 1, 2021TEAS EXTENSION RECEIVED
Wednesday, May 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 3, 2021SOU EXTENSION 3 GRANTED
Monday, May 3, 2021SOU EXTENSION 3 FILED
Monday, May 3, 2021TEAS EXTENSION RECEIVED
Tuesday, November 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 30, 2020SOU EXTENSION 2 GRANTED
Friday, October 30, 2020SOU EXTENSION 2 FILED
Friday, October 30, 2020TEAS EXTENSION RECEIVED
Tuesday, May 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, May 3, 2020SOU EXTENSION 1 GRANTED
Sunday, May 3, 2020SOU EXTENSION 1 FILED
Sunday, May 3, 2020TEAS EXTENSION RECEIVED
Tuesday, November 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 5, 2019ASSIGNED TO LIE
Friday, July 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 26, 2019EXAMINER'S AMENDMENT ENTERED
Friday, July 26, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 26, 2019EXAMINERS AMENDMENT E-MAILED
Friday, July 26, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, July 25, 2019ASSIGNED TO EXAMINER
Wednesday, July 17, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, July 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 11, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

verify research medical trials clinical professionals pharmaceuticals information scientific providing field